MMedXYNews
Ask AIHomeVideos
MedXY AI/MedXY News/Tag: survival outcomes

survival outcomes

Latest news

Tag

news

Complete Surgical Resection Enhances Survival in High-Risk Neuroblastoma: Insights from COG ANBL0532 Trial

Complete resection of the primary tumor significantly improves survival outcomes and reduces local progression without increasing surgical complications in high-risk neuroblastoma patients.

Oct 11, 2026
Cardiology

In-Hospital Cardiac Arrest in China: Incidence, Care Processes, and Survival Outcomes in a Multicenter Prospective Study

This multicenter Chinese registry study reveals a high incidence of in-hospital cardiac arrest with low survival rates and highlights critical gaps in postresuscitation care and systemic factors limiting outcomes.

Oct 10, 2026Sign in to read
Hematology-Oncology

Outcomes of Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome in Young Adults: Insights from the EBMT Chronic Malignancies Working Party

This retrospective study evaluates survival outcomes and risk factors associated with allogeneic hematopoietic cell transplantation in young adults (18-40 years) with myelodysplastic syndrome, revealing encouraging survival rates and highli

Oct 8, 2026
news

Ovarian-Sparing Surgery in Early-Stage Adult Granulosa Cell Tumors: Comparable Survival Outcomes to Bilateral Oophorectomy

This study demonstrates that ovarian-sparing surgery in premenopausal patients with early-stage adult granulosa cell tumors offers survival outcomes similar to bilateral salpingo-oophorectomy, supporting fertility-preserving options in clin

Oct 6, 2026
Clinical Updates

Contemporary Surgical Management of Vulvar Cancer: Balancing Improved Survival with Increased Reoperation Rates — Insights from a Finnish Nationwide Study

This review synthesizes evidence that modern personalized surgical strategies for vulvar squamous cell carcinoma enhance survival outcomes despite higher reoperation rates, emphasizing evolving surgical techniques, sentinel lymph node biops

Sep 27, 2026Sign in to read
Hematology-Oncology

Global Real-World Evidence Shows Survival Benefit of Maintenance Therapy Post-Autologous Stem Cell Transplant in Multiple Myeloma

Maintenance therapies—lenalidomide, thalidomide, and bortezomib—significantly improve survival after autologous stem cell transplant for multiple myeloma, regardless of initial response status, based on a large global registry analysis.

Sep 22, 2026Sign in to read
Diabetes & Endocrinology

Evaluating First-Line Chemotherapy Strategies in Anaplastic Thyroid Cancer: Insights from a German Multicenter Registry

A multicenter German registry study comparing carboplatin/paclitaxel to other chemotherapy regimens in anaplastic thyroid cancer found no survival advantage, highlighting the importance of molecular diagnostics and multimodal treatment appr

Sep 21, 2026Sign in to read
news

Immunotherapy in Head and Neck Squamous Cell Carcinoma with Low PD-L1 Expression: A Meta-Analytic Insight into Survival Outcomes

A meta-analysis reveals immune checkpoint inhibitors may reduce survival in head and neck squamous cell carcinoma patients with PD-L1 combined positive scores less than 1, signaling caution in this subgroup’s treatment.

Sep 21, 2026
Hematology-Oncology

Contemporary Outcomes of Autologous Stem Cell Transplantation in AL Amyloidosis: Insights from a Decade-Long Multicenter Study

A multicenter retrospective study of 1047 AL amyloidosis patients undergoing autologous stem cell transplantation (2010–2020) demonstrates improved safety, deep hematologic responses, and durable survival, affirming ASCT’s vital role in tre

Sep 20, 2026Sign in to read
Clinical Updates

Germline Lymphoma-Predisposing Variants: Influence on Age at Diagnosis and Survival Outcomes in Pediatric Patients

This review synthesizes current evidence on germline lymphoma-predisposing variants, highlighting their impact on earlier cancer onset and variable survival rates in pediatric lymphoma patients, underscoring implications for genetic screeni

Sep 16, 2026Sign in to read
Hematology-Oncology

Comparing CHOP and CHOEP/EPOCH Regimens in Aggressive Adult T-Cell Leukemia/Lymphoma: Insights from an International Cohort Study

This international cohort study evaluates the effectiveness of CHOEP/EPOCH versus CHOP chemotherapy in aggressive adult T-cell leukemia/lymphoma, revealing subtype-specific survival benefits in lymphomatous ATL but inconclusive results in a

Sep 16, 2026Sign in to read
Diabetes & Endocrinology

Impact of Hypercortisolism Severity on Outcomes in Adrenocortical Carcinoma with Cushing’s Syndrome

This study reveals that the severity of hypercortisolism in adrenocortical carcinoma patients with Cushing’s syndrome correlates with higher metastatic risk and worse survival outcomes, highlighting its role as a marker of tumor aggressiven

Sep 15, 2026
Critical Care

Angioembolization vs. Surgery in Penetrating Hepatic Trauma: Balancing Survival and Hospital Stay

In penetrating liver trauma, angioembolization offers survival outcomes comparable to surgery but is linked to longer hospital and ICU stays, highlighting the need for strategic patient selection and multidisciplinary care integration.

Sep 13, 2026Sign in to read
General Surgery

Clinical Outcomes and Prognostic Factors in Lung Metastases Following Gastrectomy for Gastric Cancer

This review summarizes the clinical characteristics, disease course, and survival outcomes of lung metastases after gastrectomy in gastric cancer patients, highlighting prognostic factors and the role of pulmonary metastasectomy.

Sep 7, 2026
news

Enhancing Care for Head and Neck Cancer Patients: Insights from a Novel Subspecialty Outpatient Palliative Medicine Clinic

A surgeon-led outpatient palliative care clinic for head and neck cancer patients demonstrated significant symptom improvement, prolonged survival, and high rates of home or hospice deaths, underscoring its value in multidisciplinary cancer

Sep 2, 2026Sign in to read
General Surgery

Neoadjuvant Chemotherapy with or without Radiotherapy in Resected Pancreatic Ductal Adenocarcinoma: Impact on Outcomes

A propensity-matched study shows adding radiotherapy to neoadjuvant chemotherapy improves pathologic response but does not enhance survival or reduce recurrence in resected pancreatic ductal adenocarcinoma.

Aug 31, 2026
General Surgery

Adjuvant Chemotherapy in Distal Bile Duct Carcinoma: Insights from Real-World German Cancer Registry Data

Adjuvant chemotherapy shows survival benefits in select subgroups of distal bile duct carcinoma patients post-surgery, emphasizing the need for tailored treatment strategies and further prospective research.

Aug 28, 2026
General Surgery

Maximizing Outcomes in Locally Advanced Pancreatic Cancer with Hypofractionated Ablative Radiation Therapy

Hypofractionated ablative radiation therapy after induction chemotherapy shows promise in patients with locally advanced pancreatic cancer, improving resectability and 2-year survival while maintaining acceptable safety profiles.

Aug 2, 2026
news

MLH1 Promoter Hypermethylation Does Not Impact Survival Outcomes in dMMR Endometrial Cancer Treated with Immune Checkpoint Inhibitors

This study analyzes real-world data showing that MLH1 promoter hypermethylation and Lynch syndrome-associated genetic mutations confer similar response rates and survival outcomes in mismatch repair deficient endometrial cancer treated with

Aug 1, 2026
Gastroenterology

Comparing FLOT and CROSS Protocols: Survival and Recurrence in Esophageal Adenocarcinoma with Pathological Complete Response

This cohort study compares long-term survival and recurrence in esophageal adenocarcinoma patients achieving pathological complete response (pCR) after neoadjuvant FLOT chemotherapy versus CROSS chemoradiotherapy, highlighting better outcom

Jul 24, 2026
1 / 2
12
Next

Most read

  1. 01Intimate Health

    Five Benefits for Women Continuing Sexual Activity After Menopause

  2. 02Intimate Health

    Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It

  3. 03Nursing & care

    How often should a couple have sex?

  4. 04Cardiology

    Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval

  5. 05General Surgery

    Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models

Go deeper with MedXY AI

Explore the evidence behind the news.

Ask AI
MedXY briefing

Stay informed

Medical news and research updates, delivered to your inbox.

© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story